It has been confirmed that for cases issued on or after 6 April 2023, a defendant will be able to enforce costs up to “the aggregate amount in money terms of any orders for or agreements to pay or settle a claim for, damages, costs and interest”.

We outline when and why do GP practices need to update their partnership documents, and top tips on how this can be achieved efficiently.

Our Health and Justice insights focuses on the latest legal updates, statistics and good news stories across the health and justice space, complete with commentary from our specialist in-house team.

In this insight we consider tree upcoming court decisions and the impacts of those decisions on the medical malpractice and casualty insurance professionals.

The government’s response to the Medicines and Healthcare Regulatory Authority’s 2022 consultation on the future shape of clinical trials is awaited.

Claims by elite rugby players for neurological impairments alleged to arise from repetitive concussive and sub-concussive blows to the head, are gathering pace.

Module 3 of the public inquiry has a healthcare focus and includes use of the private sector during the pandemic. A virtual and streamed preliminary hearing is scheduled for 28 February 2023.

While the focus to date has been on the NHS (where the cost of Covid-19 related claims is estimated to be over £1 billion), private surgeons could face claims as well.

The courts’ appetite for making findings of fundamental dishonesty and to give custodial sentences on committal applications, shows no sign of waning.

The government plans to introduce a Transport Bill this year which is likely to propose legislation to allow the use of private e-scooters on public roads (currently illegal).

In our annual Forward View we look at some of the key topics for the year ahead ranging from the consultation on the discount rate and claims for provisional damages to the Covid-19 Inquiry and claims against private surgeons.

The Ministry of Justice (MOJ) has issued a call for evidence to inform the decision-making process for its next PIDR review (due to be completed by July 2024).